HCPCS Code C1762: Connective Tissue, Human (Includes Fascia Lata)

Key Takeaways

HCPCS code C1762 covers human connective tissue grafts including fascia lata

Used primarily in hospital outpatient and ASC settings for device billing

Requires tissue source documentation and FDA registration verification

Separate from surgeon procedure codes and billed by facility

Prior authorization often required depending on payer policy

HCPCS Code C1762: Connective Tissue, Human (Includes Fascia Lata)

Billing human connective tissue grafts requires precision. HCPCS code C1762 covers connective tissue allografts derived from human donors, including fascia lata, for facility use in surgical procedures. This device code appears on hospital outpatient and ambulatory surgery center (ASC) claims when surgeons implant processed human tissue during reconstructive or repair procedures.

The code applies when facilities supply the graft material separately from the surgeon’s technical work. CMS maintains HCPCS code C1762 as part of the Level II code set for device and supply billing. Practices billing this code work across orthopedic surgery, plastic surgery, and wound care specialties where tissue reinforcement serves structural repair needs.

What HCPCS Code C1762 Covers

HCPCS code C1762 describes connective tissue, human, including fascia lata. The code covers processed human allograft tissue supplied by FDA-registered tissue banks. Fascia lata remains the most common tissue type under this code, though other connective tissue matrices qualify when derived from human donors and processed according to FDA tissue establishment regulations.

Facilities report C1762 for the graft product itself, not the surgeon’s implantation work. The surgeon bills the appropriate CPT procedure code separately. For example, a plastic surgeon performing abdominal wall reconstruction with fascia lata graft bills the CPT code for the repair procedure. The facility bills C1762 for the tissue graft supplied during that same operative session.

According to CMS HCPCS guidance, the code applies when tissue undergoes minimal manipulation and remains intended for homologous use. More heavily processed tissue products may require different HCPCS codes depending on regulatory classification. Tissue banks provide product labelling that clarifies whether C1762 is the correct code for a specific graft.

Common Procedures Using HCPCS Code C1762

Orthopedic surgeons use fascia lata grafts for ligament reconstruction, particularly in knee procedures. Plastic surgeons apply connective tissue allografts for soft tissue repair in breast reconstruction, abdominal wall defects, and facial reconstruction. Wound care specialists use these grafts for chronic wound coverage when autologous tissue is insufficient or unavailable.

The tissue functions as structural support. In a rotator cuff repair, the surgeon may reinforce the repair site with a connective tissue graft to improve healing outcomes. The surgeon reports the rotator cuff repair CPT code, while the facility reports C1762 for the graft material. This dual-coding approach separates the professional service from the device supply.

Hernia repairs frequently involve connective tissue reinforcement. When mesh alone proves inadequate, surgeons layer fascia lata over defects to provide biological scaffolding. The facility bills C1762 alongside the hernia repair procedure code. Plastic surgery EMR systems track these combinations to ensure both codes appear on the claim.

Orthopedic Applications

Knee ligament reconstruction uses fascia lata when autograft harvest sites carry complications. The graft substitutes for patellar tendon or hamstring tissue in ACL repairs. Shoulder procedures apply connective tissue for superior capsular reconstruction when massive rotator cuff tears exceed primary repair capability. Ankle stabilization procedures employ these grafts for lateral ligament reinforcement in chronic instability cases.

Plastic Surgery and Wound Care Uses

Breast reconstruction after mastectomy often requires tissue reinforcement for implant coverage. Surgeons position connective tissue grafts between the pectoralis muscle and implant to create a biological barrier. Abdominal wall reconstruction for ventral hernias or post-bariatric surgery defects relies on these grafts when synthetic mesh alone risks infection. Complex wound beds use connective tissue as a dermal substitute when skin grafting requires vascular support.

Documentation Requirements for C1762 Billing

Claims for HCPCS code C1762 require specific tissue documentation. Payers expect facilities to demonstrate the tissue source, processing method, and FDA registration status. Operative notes must describe the graft product by name, lot number, and dimensions. The tissue bank invoice provides lot traceability and confirms FDA establishment registration.

Medicare Administrative Contractors review claims for tissue source verification. The operative report should state “human connective tissue allograft” rather than generic terms like “tissue graft” or “biological mesh.” Product-specific language ties the claim to verifiable inventory. Claims management software with tissue inventory integration automatically pulls this detail into billing records.

Documentation must separate the graft from the surgical procedure. When an orthopedic surgeon performs ligament reconstruction with fascia lata, the operative note describes both the reconstruction technique and the tissue graft as distinct elements. The surgeon’s dictation should reference graft dimensions (e.g., “4cm x 8cm fascia lata allograft”) and placement location. This detail supports both the surgeon’s CPT code and the facility’s C1762 charge.

Tissue Source and Traceability

FDA regulations require tissue banks to maintain donor screening records and processing documentation. Facilities billing C1762 should retain tissue bank certificates that confirm FDA registration and Good Tissue Practice compliance. The lot number on the graft package links to these upstream records. Payers audit tissue source documentation when reviewing high-cost graft claims.

Tissue bank invoices serve as billing support. The invoice lists the product name, lot number, expiration date, and unit cost. When facilities submit claims, they reference this invoice to justify the C1762 charge. Some payers require invoice submission with initial claims for tissue products exceeding cost thresholds. Practice management software store these documents alongside the claim for audit readiness.

HCPCS Code C1762 Reimbursement and Coverage

Medicare reimburses C1762 under the Outpatient Prospective Payment System (OPPS) for hospital outpatient departments and under the ASC fee schedule for ambulatory surgery centers. The reimbursement amount varies by setting and geographic location. OPPS groups C1762 within a device category that receives separate payment beyond the procedure’s base rate.

Commercial payers set their own coverage policies for connective tissue grafts. Some insurers classify fascia lata as a covered device under surgical benefit categories, while others apply medical necessity criteria tied to specific diagnoses. Prior authorization requirements differ by payer and by procedure type. A plastic surgeon using fascia lata for breast reconstruction may face different authorization rules than an orthopedic surgeon using the same tissue for ligament repair.

According to CMS fee schedule data, tissue graft reimbursement reflects acquisition cost plus handling fees. Facilities negotiate tissue pricing with suppliers based on volume and contract terms. The gap between acquisition cost and reimbursement determines whether the facility profits or loses on tissue graft cases. Tracking this margin requires integration between inventory systems and billing platforms.

Prior Authorization Considerations

Payers increasingly require prior authorization for tissue grafts before surgery. The authorization request must specify the tissue product, the surgical procedure, and the clinical indication. When a surgeon plans a hernia repair with fascia lata reinforcement, the facility submits authorization documentation that includes the diagnosis code, the planned CPT code, and the anticipated C1762 charge.

Authorization denials often stem from insufficient medical necessity justification. Payers expect documentation that explains why synthetic mesh or autograft tissue is inadequate. A patient with previous mesh infection or tobacco use affecting wound healing presents stronger medical necessity for allograft tissue. The surgeon’s preoperative notes should document these factors to support authorization requests.

Simplify Tissue Graft Billing

Track tissue inventory, link lot numbers to claims, and automate C1762 documentation with Pabau's claims management platform.

Book a demo

Common Billing Errors with HCPCS Code C1762

Billing C1762 without the corresponding surgeon procedure code triggers claim edits. Payers expect tissue device codes to appear alongside the surgical CPT code that describes implantation. A standalone C1762 claim without a paired procedure code signals incomplete billing and results in denial.

Duplicate billing occurs when both the surgeon and facility report C1762. The surgeon bills the procedure code for implanting the graft, but should not bill the device code. The facility owns the tissue inventory and reports C1762 as a supply item. When surgeons mistakenly bill C1762 on their professional claims, payers reject the claim as duplicate billing.

Incorrect unit reporting causes reimbursement errors. C1762 bills per unit of tissue supplied, typically one unit per graft piece. If a surgeon uses two separate fascia lata grafts during a single procedure, the facility reports C1762 with quantity two. Billing one unit when two grafts were used results in underpayment. Overcounting units without documentation triggers audits.

Diagnosis Code Pairing Issues

HCPCS code C1762 requires a diagnosis code that supports the surgical procedure. When billing a hernia repair with tissue graft, the primary diagnosis should reflect the hernia type and location. Using a vague or unrelated diagnosis code weakens medical necessity and invites claim review. The diagnosis must link logically to both the surgical procedure and the tissue graft use.

Payers check for diagnosis-procedure alignment. A claim showing C1762 with a diagnosis code for skin infection but no wound repair procedure code raises questions. The billing staff should verify that the diagnosis on the facility claim matches the diagnosis on the surgeon’s claim. Mismatches between professional and facility claims delay payment.

Appeals and Denials for C1762 Claims

Denials for HCPCS code C1762 typically cite lack of medical necessity, insufficient documentation, or incorrect coding. When a payer denies a C1762 claim, the first step is reviewing the denial reason code. Denial codes indicating “not medically necessary” require clinical documentation that demonstrates why the tissue graft was essential for the procedure.

Appeal letters should reference the operative report, tissue bank documentation, and clinical literature supporting allograft use in the specific procedure. For example, an appeal for a denied breast reconstruction C1762 claim might include published studies showing improved outcomes with acellular dermal matrix in implant-based reconstruction. The appeal connects the clinical evidence to the patient’s case details.

Documentation denials often result from missing tissue source information. If the payer states “documentation does not support the charge,” the appeal should include the tissue bank invoice, the lot number from the operative note, and the FDA registration certificate. Electronic health record systems with integrated document management streamline this evidence gathering for appeals.

Resubmission Strategies

When correcting coding errors, facilities resubmit the claim with the correct information and a detailed explanation. If the initial claim billed C1762 without the surgeon procedure code, the resubmission includes both codes and a cover letter explaining the error. Payers process corrected claims faster when the resubmission clearly identifies what changed.

Some denials reflect policy changes. A payer may update their coverage policy to exclude certain tissue types from C1762 reimbursement. When this occurs, facilities should request a copy of the updated policy and compare it to the tissue product used. If the tissue falls outside the new policy, the appeal should argue that the procedure occurred before the policy effective date or request an exception based on medical necessity.

Expert Picks

Managing complex tissue graft billing across multiple payers? Claims Management Software automates code pairing, tracks authorization requirements, and flags denials for faster appeals.

Need to document surgical procedures with precision? Digital Forms capture tissue lot numbers, graft dimensions, and placement details directly in the operative workflow.

Want to reduce billing errors across your surgical practice? Plastic Surgery EMR links procedure codes, device codes, and inventory data to eliminate missing charges.

Conclusion

HCPCS code C1762 represents a critical billing element for facilities supplying human connective tissue grafts. Accurate coding requires clear documentation of tissue source, lot traceability, and pairing with the appropriate surgical procedure code. Practices that integrate tissue inventory tracking with their claims systems reduce denials and streamline reimbursement.

The gap between tissue acquisition cost and reimbursement determines financial viability for these cases. Facilities must monitor payer policies, maintain thorough documentation, and respond quickly to denials with detailed appeals. As tissue graft technology advances, staying current with coding updates and coverage policies ensures claims remain compliant and profitable.

Frequently Asked Questions